Sailax Pharma Consulting
Regulatory Affairs
We provide high-level regulatory leadership and program governance that enable successful regulatory outcomes across markets. Our Regulatory Affairs capability includes strategic planning, readiness assessments, regulatory governance, submission oversight, and ongoing lifecycle management. (Detailed, standalone pages are available for each specialized activity — for example: Product Registration & Submissions; Regulatory Strategy & Compliance; Regulatory Intelligence — each developed separately.)
Service Overview
Sailax Pharma Consulting provides authoritative Regulatory Affairs services that establish and sustain regulatory compliance across the product lifecycle. Our Regulatory Affairs practice focuses on strategic planning, regulatory governance, and liaison with competent authorities to ensure timely market access while protecting patient safety and corporate reputation.
Who we support
Regulatory leaders, development teams, quality and compliance departments, and business units within pharmaceutical, biotechnology, medical device, and nutraceutical companies seeking pragmatic regulatory guidance and dependable regulatory operations.
What We Deliver
We provide high-level regulatory leadership and program governance that enable successful regulatory outcomes across markets. Our Regulatory Affairs capability includes strategic planning, readiness assessments, regulatory governance, submission oversight, and ongoing lifecycle management. (Detailed, standalone pages are available for each specialized activity — for example: Product Registration & Submissions; Regulatory Strategy & Compliance; Regulatory Intelligence — each developed separately.)
How Clients Benefit
Clear value at every stage of partnership.
Strategic clarity
Clear regulatory pathways and decision frameworks reduce uncertainty and accelerate planning.
Risk reduction
Proactive governance, gap remediation and readiness reduce the likelihood of regulatory setbacks.
Operational efficiency
Centralized processes and standards improve cross-functional collaboration and reduce rework.
Sustained compliance
Ongoing oversight ensures post-approval obligations are met and the product remains market-compliant.
Our Approach
Structured, transparent, and collaborative.
Stakeholder alignment
Establish regulatory objectives with product, clinical, CMC, and commercial teams.
Core Deliverables
Tangible outputs that keep programs compliant and moving.
Regulatory program plan and milestone roadmap
Gap assessment and remediation plan
Regulatory governance documents (RACI, KPIs, decision logs)
Authority engagement plans and briefing materials
Audit-ready records and compliance trackers
Engagement Models
Advisory & strategy
Short-term strategic engagements for planning or high-level decisions.
Program leadership
Long-term oversight of regulatory programs and cross-functional coordination.
Co-sourced operations
Embedded support for submission management, authoring oversight, and governance.
Regulatory footprint & standards
We align activities with international standards and agency expectations (ICH, USFDA, EMA, Health Canada, PMDA, TGA, CDSCO, WHO and others) and tailor approaches to market-specific requirements.